Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
|2||Active, not recruiting||
Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer
Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
† Indicates status has not been verified in more than two years